visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Aquinnah Pharmaceuticals

    Get Full Access

    Description

    • Aquinnah Pharmaceuticals is focused on a new area of research and development to modulate neurodegenerative stress granules, believed to be important in the pathology of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The medical need for ALS is very high as there are currently no effective treatments for this devastating neurodegenerative disease. ALS progresses rapidly, eventually affecting muscles in the arms, legs, face, diaphragm, and chest. Today, approximately 60% of patients with ALS will not survive beyond three years following diagnosis, with 10% of new patients surviving at least 10 years. Aquinnah Pharmaceuticals has identified lead molecules designed to prevent and reverse the pathological stress granules in affected patients. In addition to their use in ALS, these compounds also show promise as a potential treatment for cognition impairment in patients with Alzheimers disease and other neurodegenerative diseases.
    • location

      Headquarters:610 Main St , Cambridge, Massachusetts, United States

      More
    • Aquinnah Pharmaceuticals phone

      Phone Number:

    • Aquinnah Pharmaceuticals website

      Website: https://www.aquinnahpharmaceuticals.com

    • Aquinnah Pharmaceuticals employees

      Employees:10

    • Aquinnah Pharmaceuticals revenue

      Revenue:$10 - 50M

    • Aquinnah Pharmaceuticals legal name

      Legal Name:Aquinnah Pharmaceuticals

    • Aquinnah Pharmaceuticals's Social Media

      Aquinnah Pharmaceuticals linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Aquinnah Pharmaceuticals

    Glenn Larsen

    Co-Founder, President And Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    James Gabriel

    Chief Business Officer

    Benjamin Wolozin

    Co-Founder And Chief Scientific Officer

    Frequently Asked Questions regarding Aquinnah Pharmaceuticals

    • Where are Aquinnah Pharmaceuticals's Headquarters?

      Aquinnah Pharmaceuticals's Headquarters are in 610 Main St ,Cambridge,Massachusetts,United States

    • What is Aquinnah Pharmaceuticals's official website?

      Aquinnah Pharmaceuticals's official website is https://www.aquinnahpharmaceuticals.com

    • What is Aquinnah Pharmaceuticals's Revenue?

      Aquinnah Pharmaceuticals's revenue is $10 - 50M

    • What is Aquinnah Pharmaceuticals's NAICS code?

      Aquinnah Pharmaceuticals's NAICS code is 541713

    • How many employees are working in Aquinnah Pharmaceuticals

      Aquinnah Pharmaceuticals has 10 employees

    • What is Aquinnah Pharmaceuticals's Industry?

      Aquinnah Pharmaceuticals is in the industry of Biotechnology

    • Who is Aquinnah Pharmaceuticals's CEO?

      Aquinnah Pharmaceuticals's CEO is Glenn Larsen

    • Who is Aquinnah Pharmaceuticals's Chief Business Officer?

      Aquinnah Pharmaceuticals's Chief Business Officer is James Gabriel

    Company Directory